Ogugua Ajemba
Anatomic Pathology & Clinical Pathology Victorville, CA
NPI 1245506989 CMS profile 6631345
15248 Eleventh St, Victorville, CA 92395
General payments
$0
Research payments
$0
Ownership & investment interest
$0
The CMS Open Payments record contains no reported payments to Ogugua Ajemba of Victorville, CA.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
Other Anatomic Pathology & Clinical Pathology in California
Serge Alexanian
Anatomic Pathology & Clinical Pathology · Los Angeles, CA
Brian Cone
Anatomic Pathology & Clinical Pathology · Los Angeles, CA
John Blaustein
Anatomic Pathology & Clinical Pathology · Santa Barbara, CA
Henry Tsai
Anatomic Pathology & Clinical Pathology · Huntington Beach, CA
Stewart Comer
Anatomic Pathology & Clinical Pathology · Santa Barbara, CA
Eric Vail
Anatomic Pathology & Clinical Pathology · West Hollywood, CA
Related records
Anatomic Pathology & Clinical Pathology in California
Practitioners in the same specialty and state, ranked by reported value.
All Anatomic Pathology & Clinical Pathology
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.